Geographic heterogeneity of cellular characteristics of acute myeloid leukemia: A comparative study of Australian and Japanese adult cases

Leukemia

Volumn 14, Issue 1, 2000, Pages 163-168

  Nakase, K ^a,d   Bradstock, K ^b   Sartor, M ^b   Gottlieb, D ^b   Byth, K ^b   Kita, K ^a   Shiku, H ^a   Kamada, N ^c  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b WESTMEAD HOSPITAL   (Australia)

^c HIROSHIMA UNIVERSITY   (Japan)

^d SAISEIKAI MATSUSAKA GENERAL HOSPITAL   (Japan)

Author keywords

Acute myeloid leukemia; CD19; M2; t(8; 21)

Indexed keywords

CD14 ANTIGEN; CD19 ANTIGEN; CD34 ANTIGEN; HLA DR ANTIGEN; MICROSOMAL AMINOPEPTIDASE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; CANCER CLASSIFICATION; CANCER GENETICS; CHROMOSOME 11Q; CHROMOSOME 16; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 17; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 8; COMPARATIVE STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0033984685     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401638     Document Type: Article

References (35)

1. Kadin ME, Berad CW, Nanba K, Wakasa H. Lymphoproliferative disease in Japan and Western countries. Hum Pathol 1983; 14: 7-45-772.
2. Amakawa R, Fukuhara S, Ohno H, Doi S, Oguma S, Tanabe S, Yamabe H, Edamura S, Tomono N, Nasu K, Koelama Y, Shiomura T, Abe M, Wakasa H, Uchino H. Involvement of bcl-2 genes in Japanese follicular lymphoma. Blood 1989; 73: 787-791.
3. Asou H, Takechi M, Tanaka K, Tashiro S, Dohy H, Ohno R, Kamada N. japanese B cell chronic lymphocytic leukaemia: a cytogenetic and molecular biological study. Br J Haematol 1993; 85: 492-497.
4. Second MIC Cooperative Study Group. Morphologic, and cytogenetic (MIC) working classification of acute myeloid leukemias. Cancer Genet Cytogenet 1988; 30: 1-15.
5. Head DR. Revised classification of acute myeloid leukemia. Leukemia 1996; 10: 1826-1831.
6. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposals for the classification of the acute leukaemias: French-American-British Cooperative Group. Br J Haematol; 1976; 33: 451-458.
7. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia: a report ot the French-American-British Cooperative Group. Ann Intern Med 1985; 103: 626-629.
8. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnic k HR, Sultan C. Proposals for the classilication of the myelodysplastic syndromes. Br J Haematol 1982; 81: 189-199.
9. Bradstock KF, Kirk J, Grimsley PG, Kabral A, Hughes WG. Unusual immunophenotypes in acute leukaemias: incidence and clinical correlations. Br J Haematol 1989; 72: 512-518.
10. Nakase K, Kita K, Otsuji A, Anazawa H, Hoshino K, Sekine T, Shirakawa S, Tanaka I, Nasu K, Tsutani H, Dohy H, Tsudo M. Diagnostic and clinical importance of interleukin-2 receptor alpha chain expression on non-T cell acute leukaemia cells. Br J Haematol 1992; 80: 317-326.
11. Asou H, Tashiro S, Hamamoto K, Otsuji A, Kita K, Kamada N. Establishment of a human acute 1 myeloid leukemia cell line (Kasumi-1) with 8:21 chromosome translocation. Blood 1991; 77: 2301-2306.
12. Armitage P, Berry G. Statiscal Methods in Medical Research. Second edn. Blackwell Scientific: Oxford, 1987.
13. Kita K, Nakase K, Miwa H, Masuya M, Nishii K, Morita N, Takakura N, Otsuji A, Shirakawa S, Ueda T, Nasu K, Kyo T, Dohy H, Kamacla N. Phenotypical characteristics ot acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: frequent expression of immature B cell antigen CD19 together with stem cell antigen CD34 Blood 1992; 80: 470-477.
14. Hurwitz CA, Raimondi SC, Head D, Krance R, Mirro J, Kalwinsky DK, Ayers GD, Behm FG. Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children. Blood 1992; 80: 3182-3188.
15. De The H, Chomienne C, Lanotte M, Degos L, Dejean A. The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor α gene to a novel transcribed locus. Nature 1990; 347: 558-561.
16. Goddard A, Borrow J, Freemont P, Solomon E. Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science 1991; 254: 1371-1373.
17. Tien H-F, Wang C-H, Lee F-Y, Chuang S-M, Chen Y-C, Lin D-T, Shell M-C, Liu C-H. Chromosome studies on 30 Chinese patients with acute nonlymphocytic leukemia in Taiwan. Cancer Genet Cytogenet 1988; 32: 101-108.
18. Johansson B, Mertens F, Mitelman F. Geographic heterogeneity of neoplasia-associated chromosome aberrations. Genes Chromos Cancer 1991; 3: 1-7.
19. Mitelman F. Geographic heterogeneity of chromosome aberrations in hematologic disorders. Cancer Genet Cytogenet 1986; 20: 203-208.
20. +/DR phenotypes with shorter survival. Leukemia 1992; 6: 393-399.
21. Brandt JT, Tisone JA, Bohman JE, Theil KS. Aberrant expression of CD19 as a marker of monocytic lineage in acute myelogenous leukemia. Am J Clin Pathol 1997; 107: 283-291.
22. Ball ED, Davis RB, Griffin JD, Mayer RJ, Davey FR, Arthur DC, Wurster-Hill D, Noll W, Elghetany MT, Allen SL, Rai K, Lee EJ, Schiffer CA, Bloomfield CD. Prognostic value of lymphocyte surface markers in acute myeloid leukemia. Blood 1991; 77: 2242-2250.
23. Tien H-F, Wang C-H, Chen Y-C, Shen M-C, Lin D-T, Lin K-H. Characterization of acute myeloid leukemia (AML) co-expressing lymphoid markers: different biologic features between T cell antigen positive and B cell antigen positive AML. Leukemia 1993; 7: 688-695.
24. Drexler HG, Thiel E, Ludwig W-D. Acute myeloid leukemias expressing lymphoid antigens: diagnostic incidence and prognostic significant. Leukemia 1993; 7: 489-498.
25. Bradstock K, Matthews J, Benson E, Page F, Bishop J. Prognostic-value of immunophenotyping in acute myeloid leukemia. Blood 1994; 84: 1220-1225.
26. Launder TM, Bray RA, Stempora L, Chenggis ML, Farhi DC. Lymphoid-associated antigen expression by acute myeloid leukemia. Am J Clin Pathol 1995; 106: 185-191.
27. Look AT, Peiper SC, Rebentisch MB, Ashmun RA, Roussel MF, Rettenmier CW, Sherr CI. Transfer and expression of the gene encoding a human myeloid membrane antigen (gp150). J Clin Invest 1985; 75: 569-579.
28. Ashmun RA, Peiper SC, Rebentisch MB, Look AT. Expression of the human monocyte membrane antigen gp55 by murine fibroblasts after DNA-mediated gene transfer. Blood 1986; 69: 886-892.
29. Drexler HG. Classification of acute myeloid leukemias - a comparison of FAB and immunophenotyping. Leukemia 1987; 1: 697-705.
30. Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y, Ohki M. The t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia clustered within a limited region of a novel gene, AML1. Proc Natl Acad Sci USA 1991; 88: 10431-10434.
31. Erikson P, Gao J, Chang K-S, Look T, Whisenant E, Raimondi S, Lasher R, Trujillo J, Rowley JD, Drabkin H. Identification of breakpoints in t(8;21 ) AML and isolation of a fusion transcript with similarity to Drosophila segmentation gene runt. Blood 1992; 80: 1825-1831.
32. Nucifora G, Rowley JD. AML1 and the 8;21 and 3;21 translocalions in acute and chronic myeloid leukemia. Blood 1995; 86: 1-14.
33. Nucifora G, Birn D, Espinosa R, LeBeau M, Erikson P, Roulston P, McKeithan TW, Drabkin H, Rowley JD. Involvement of the AML1 gene in the t(3;21) in therapy-related leukemia and in chronic myeloid leukemia in blast crisis. Blood 1993; 81: 2728-2734.
34. Claxlon DF, Liu P, Hsu HB, Marlton P, Hester J, Collins F, Deissoroth AB, Rowley JD, Siciliano MJ. Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemia. Blood 1994; 83: 1750-1756.
35. Golub TR, Barker GF, Bohlander SK, Hiebert SW, Ward DC, Bray-Ward P, Morgan E, Raimondi SC, Rowley JD, Gilliland DG. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci USA 1995; 92: 4917-4921.